Xenon Pharmaceuticals (XENE) Interest Expenses (2013 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Interest Expenses of $8.3 million for Q1 2026, down 15.05% year-over-year from $9.7 million in Q1 2025, and up 1806.68% quarter-over-quarter from $434000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Interest Expenses (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Interest Expenses for 14 consecutive years, with $8.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 15.05% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (down 15.05% YoY), while the FY2025 annual figure was $346.8 million, up 211.86% from the prior year.
- Interest Expenses improved to $8.3 million in Q1 2026 per XENE's latest filing, from $434000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $12.7 million in Q3 2023 and bottomed at $281000.0 in Q4 2022.
- Historically, Interest Expenses has averaged $5.6 million across 5 years, with a median of $2.3 million in 2023.
- Annual changes were most pronounced in 2022 — Interest Expenses soared 1915.97% — and 2025, when it tumbled 90.96%.
- Xenon Pharmaceuticals' Interest Expenses stood at $281000.0 in 2022, then jumped by 44.13% to $405000.0 in 2023, then advanced by 5.43% to $427000.0 in 2024, then rose by 1.64% to $434000.0 in 2025, then soared by 1806.68% to $8.3 million in 2026.
- Business Quant data shows XENE's Interest Expenses at $8.3 million in Q1 2026, $434000.0 in Q4 2025, and $9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | 7.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.09 Mn |
| Jun 30, 2026 | 7.09 Mn |
| Mar 31, 2026 | 8.28 Mn |
| Mar 31, 2026 | 8.28 Mn |
| Dec 31, 2025 | 434,000.00 |
| Dec 31, 2025 | 434,000.00 |
| Sep 30, 2025 | 9.27 Mn |
| Sep 30, 2025 | 9.27 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 9.74 Mn |
| Mar 31, 2025 | 9.74 Mn |
| Dec 31, 2024 | 427,000.00 |
| Dec 31, 2024 | 427,000.00 |
| Sep 30, 2024 | 11.09 Mn |
| Sep 30, 2024 | 11.09 Mn |
| Jun 30, 2024 | 11.42 Mn |
| Jun 30, 2024 | 11.42 Mn |
| Mar 31, 2024 | 11.93 Mn |
| Mar 31, 2024 | 11.93 Mn |